A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States.
Appl Radiat Isot
; 66(2): 252-60, 2008 Feb.
Article
em En
| MEDLINE
| ID: mdl-17933545
ABSTRACT
A blind performance test was conducted to evaluate dose-calibrator measurements at nuclear pharmacies in the United States (US). Two test-sample geometries were chosen to represent those used for measurements of 90Y-ibritumomab tiuxetan (ZEVALIN). The radioactivity concentration of test-samples was verified by the US National Institute of Standards and Technology. Forty-five results were reported by 10 participants. Eighty percent of reported values were within the US Pharmacopoeia content standard (+/-10%) for 90Y-ZEVALIN. All results were within US Nuclear Regulatory Commission conformance limits (+/-20%) for defining therapeutic misadministrations.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Radioisótopos de Ítrio
/
Compostos Radiofarmacêuticos
/
Anticorpos Monoclonais
Tipo de estudo:
Evaluation_studies
/
Guideline
Limite:
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article